CN106434912B - Application of microRNA marker related to litter size of pig - Google Patents
Application of microRNA marker related to litter size of pig Download PDFInfo
- Publication number
- CN106434912B CN106434912B CN201610841933.2A CN201610841933A CN106434912B CN 106434912 B CN106434912 B CN 106434912B CN 201610841933 A CN201610841933 A CN 201610841933A CN 106434912 B CN106434912 B CN 106434912B
- Authority
- CN
- China
- Prior art keywords
- mir
- beta
- zeb1
- gene
- expression
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003550 marker Substances 0.000 title claims abstract description 20
- 239000002679 microRNA Substances 0.000 title abstract description 21
- 108700011259 MicroRNAs Proteins 0.000 title abstract description 5
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 85
- 108091059135 miR-429 stem-loop Proteins 0.000 claims abstract description 71
- 101000785626 Homo sapiens Zinc finger E-box-binding homeobox 1 Proteins 0.000 claims abstract description 65
- 230000014509 gene expression Effects 0.000 claims abstract description 61
- 108010066058 beta Subunit Luteinizing Hormone Proteins 0.000 claims abstract description 55
- 102100026457 Zinc finger E-box-binding homeobox 1 Human genes 0.000 claims abstract description 49
- 230000001817 pituitary effect Effects 0.000 claims abstract description 33
- 241000282887 Suidae Species 0.000 claims abstract description 30
- 238000000034 method Methods 0.000 claims abstract description 26
- 230000008569 process Effects 0.000 claims abstract description 6
- 230000002401 inhibitory effect Effects 0.000 claims abstract description 4
- 238000006243 chemical reaction Methods 0.000 claims description 35
- 238000010839 reverse transcription Methods 0.000 claims description 32
- 210000003101 oviduct Anatomy 0.000 claims description 25
- 238000011144 upstream manufacturing Methods 0.000 claims description 18
- 108091062206 Sus scrofa miR-429 stem-loop Proteins 0.000 claims description 17
- 239000000203 mixture Substances 0.000 claims description 16
- 238000003757 reverse transcription PCR Methods 0.000 claims description 15
- 230000001105 regulatory effect Effects 0.000 claims description 10
- 239000002299 complementary DNA Substances 0.000 claims description 9
- 238000013461 design Methods 0.000 claims description 8
- 229910021642 ultra pure water Inorganic materials 0.000 claims description 8
- 239000012498 ultrapure water Substances 0.000 claims description 8
- 102100034343 Integrase Human genes 0.000 claims description 7
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 claims description 7
- 230000033228 biological regulation Effects 0.000 claims description 7
- 239000000872 buffer Substances 0.000 claims description 7
- 230000002596 correlated effect Effects 0.000 claims description 6
- 238000002123 RNA extraction Methods 0.000 claims description 5
- 239000007850 fluorescent dye Substances 0.000 claims description 5
- 108010085238 Actins Proteins 0.000 claims description 4
- 108091092584 GDNA Proteins 0.000 claims description 4
- 108010043121 Green Fluorescent Proteins Proteins 0.000 claims description 4
- 102000007469 Actins Human genes 0.000 claims description 3
- 230000002194 synthesizing effect Effects 0.000 claims description 3
- 230000003828 downregulation Effects 0.000 claims description 2
- 230000000415 inactivating effect Effects 0.000 claims description 2
- 238000001514 detection method Methods 0.000 abstract description 18
- 238000009395 breeding Methods 0.000 abstract description 9
- 230000001488 breeding effect Effects 0.000 abstract description 9
- 206010062767 Hypophysitis Diseases 0.000 abstract description 4
- 230000008844 regulatory mechanism Effects 0.000 abstract description 3
- 230000007613 environmental effect Effects 0.000 abstract description 2
- 244000144972 livestock Species 0.000 abstract description 2
- 230000002829 reductive effect Effects 0.000 abstract description 2
- 101150074545 Zeb1 gene Proteins 0.000 abstract 1
- 238000002474 experimental method Methods 0.000 description 30
- 210000001519 tissue Anatomy 0.000 description 26
- 239000000523 sample Substances 0.000 description 25
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 23
- 239000000243 solution Substances 0.000 description 22
- 108091070501 miRNA Proteins 0.000 description 17
- 239000013598 vector Substances 0.000 description 17
- 238000001890 transfection Methods 0.000 description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 15
- 239000005089 Luciferase Substances 0.000 description 13
- 239000003153 chemical reaction reagent Substances 0.000 description 13
- 230000000694 effects Effects 0.000 description 13
- 238000012360 testing method Methods 0.000 description 13
- 210000004291 uterus Anatomy 0.000 description 13
- 239000012528 membrane Substances 0.000 description 12
- 239000007853 buffer solution Substances 0.000 description 11
- 239000000499 gel Substances 0.000 description 11
- 238000002156 mixing Methods 0.000 description 11
- 102000004169 proteins and genes Human genes 0.000 description 11
- 230000001850 reproductive effect Effects 0.000 description 11
- 210000003016 hypothalamus Anatomy 0.000 description 10
- 239000006228 supernatant Substances 0.000 description 10
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 9
- 210000004027 cell Anatomy 0.000 description 9
- 238000001962 electrophoresis Methods 0.000 description 9
- 210000001672 ovary Anatomy 0.000 description 9
- 239000000758 substrate Substances 0.000 description 9
- 108010052090 Renilla Luciferases Proteins 0.000 description 8
- 238000004458 analytical method Methods 0.000 description 8
- 239000012224 working solution Substances 0.000 description 8
- 239000003298 DNA probe Substances 0.000 description 7
- 108700008625 Reporter Genes Proteins 0.000 description 7
- 238000000605 extraction Methods 0.000 description 7
- 239000013612 plasmid Substances 0.000 description 7
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 6
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- 108020004414 DNA Proteins 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 108060001084 Luciferase Proteins 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 108020004999 messenger RNA Proteins 0.000 description 6
- 238000011160 research Methods 0.000 description 6
- 102000011931 Nucleoproteins Human genes 0.000 description 5
- 108010061100 Nucleoproteins Proteins 0.000 description 5
- 238000002835 absorbance Methods 0.000 description 5
- 230000009977 dual effect Effects 0.000 description 5
- 239000013604 expression vector Substances 0.000 description 5
- 239000002244 precipitate Substances 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 238000003753 real-time PCR Methods 0.000 description 5
- 230000008685 targeting Effects 0.000 description 5
- 229920000936 Agarose Polymers 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- 238000011529 RT qPCR Methods 0.000 description 4
- 238000003556 assay Methods 0.000 description 4
- 238000009739 binding Methods 0.000 description 4
- 238000005119 centrifugation Methods 0.000 description 4
- 230000002222 downregulating effect Effects 0.000 description 4
- 238000003670 luciferase enzyme activity assay Methods 0.000 description 4
- 229920003023 plastic Polymers 0.000 description 4
- 239000004033 plastic Substances 0.000 description 4
- 229920002401 polyacrylamide Polymers 0.000 description 4
- 238000012163 sequencing technique Methods 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 108020003215 DNA Probes Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 108090000331 Firefly luciferases Proteins 0.000 description 3
- 241000242739 Renilla Species 0.000 description 3
- 102000006382 Ribonucleases Human genes 0.000 description 3
- 108010083644 Ribonucleases Proteins 0.000 description 3
- 229960002685 biotin Drugs 0.000 description 3
- 235000020958 biotin Nutrition 0.000 description 3
- 239000011616 biotin Substances 0.000 description 3
- 230000000903 blocking effect Effects 0.000 description 3
- 238000012761 co-transfection Methods 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 239000012154 double-distilled water Substances 0.000 description 3
- 239000002502 liposome Substances 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 238000011002 quantification Methods 0.000 description 3
- 238000007789 sealing Methods 0.000 description 3
- KWYHDKDOAIKMQN-UHFFFAOYSA-N N,N,N',N'-tetramethylethylenediamine Chemical compound CN(C)CCN(C)C KWYHDKDOAIKMQN-UHFFFAOYSA-N 0.000 description 2
- 102000007999 Nuclear Proteins Human genes 0.000 description 2
- 108010089610 Nuclear Proteins Proteins 0.000 description 2
- 239000004677 Nylon Substances 0.000 description 2
- 229940124158 Protease/peptidase inhibitor Drugs 0.000 description 2
- 239000013614 RNA sample Substances 0.000 description 2
- 108091036066 Three prime untranslated region Proteins 0.000 description 2
- 108091023040 Transcription factor Proteins 0.000 description 2
- 102000040945 Transcription factor Human genes 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 238000007664 blowing Methods 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 239000013592 cell lysate Substances 0.000 description 2
- 230000002860 competitive effect Effects 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 229910021641 deionized water Inorganic materials 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 230000004185 hypothalamic-pituitary-gonadal axis Effects 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 239000012160 loading buffer Substances 0.000 description 2
- 230000005012 migration Effects 0.000 description 2
- 238000013508 migration Methods 0.000 description 2
- 229920001778 nylon Polymers 0.000 description 2
- 238000005457 optimization Methods 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 210000003635 pituitary gland Anatomy 0.000 description 2
- 230000001124 posttranscriptional effect Effects 0.000 description 2
- 108091008146 restriction endonucleases Proteins 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 108020004463 18S ribosomal RNA Proteins 0.000 description 1
- 108020005345 3' Untranslated Regions Proteins 0.000 description 1
- 101150033839 4 gene Proteins 0.000 description 1
- 108020005075 5S Ribosomal RNA Proteins 0.000 description 1
- 235000011330 Armoracia rusticana Nutrition 0.000 description 1
- 240000003291 Armoracia rusticana Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 1
- 238000003718 Dual-Luciferase Reporter Assay System Methods 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 241000206602 Eukaryota Species 0.000 description 1
- 108700039691 Genetic Promoter Regions Proteins 0.000 description 1
- 108010042653 IgA receptor Proteins 0.000 description 1
- 108091027977 Mir-200 Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 108020002230 Pancreatic Ribonuclease Proteins 0.000 description 1
- 102000005891 Pancreatic ribonuclease Human genes 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- 241000255969 Pieris brassicae Species 0.000 description 1
- 238000010806 PrimeScriptTM RT Reagent kit Methods 0.000 description 1
- 102100034014 Prolyl 3-hydroxylase 3 Human genes 0.000 description 1
- 108010090804 Streptavidin Proteins 0.000 description 1
- 238000000692 Student's t-test Methods 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 235000011089 carbon dioxide Nutrition 0.000 description 1
- 230000006037 cell lysis Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- YTRQFSDWAXHJCC-UHFFFAOYSA-N chloroform;phenol Chemical group ClC(Cl)Cl.OC1=CC=CC=C1 YTRQFSDWAXHJCC-UHFFFAOYSA-N 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 230000002380 cytological effect Effects 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000010864 dual luciferase reporter gene assay Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 210000002257 embryonic structure Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 235000019441 ethanol Nutrition 0.000 description 1
- HVCNNTAUBZIYCG-UHFFFAOYSA-N ethyl 2-[4-[(6-chloro-1,3-benzothiazol-2-yl)oxy]phenoxy]propanoate Chemical compound C1=CC(OC(C)C(=O)OCC)=CC=C1OC1=NC2=CC=C(Cl)C=C2S1 HVCNNTAUBZIYCG-UHFFFAOYSA-N 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 230000004720 fertilization Effects 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 238000001917 fluorescence detection Methods 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 239000003517 fume Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 238000001879 gelation Methods 0.000 description 1
- 238000012214 genetic breeding Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 210000005003 heart tissue Anatomy 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 235000020997 lean meat Nutrition 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 238000004020 luminiscence type Methods 0.000 description 1
- HWYHZTIRURJOHG-UHFFFAOYSA-N luminol Chemical compound O=C1NNC(=O)C2=C1C(N)=CC=C2 HWYHZTIRURJOHG-UHFFFAOYSA-N 0.000 description 1
- 230000002934 lysing effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000009456 molecular mechanism Effects 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 108091027963 non-coding RNA Proteins 0.000 description 1
- 102000042567 non-coding RNA Human genes 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 210000004681 ovum Anatomy 0.000 description 1
- 239000000123 paper Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 238000005191 phase separation Methods 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 238000012372 quality testing Methods 0.000 description 1
- 238000012113 quantitative test Methods 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 108010054624 red fluorescent protein Proteins 0.000 description 1
- 230000010539 reproductive behavior Effects 0.000 description 1
- 230000027272 reproductive process Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 238000003307 slaughter Methods 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 230000008010 sperm capacitation Effects 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 238000012353 t test Methods 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 230000003827 upregulation Effects 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 239000011534 wash buffer Substances 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/124—Animal traits, i.e. production traits, including athletic performance or the like
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Analytical Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The invention belongs to the technical field of livestock molecular biology, and provides application of a microRNA marker related to pig litter size, wherein miR-429, ZEB1 and LH beta are used as marker genes, and the relative farrowing capacity of different sow individuals is judged by comparing the relative expression amounts of the marker genes miR-429, ZEB1 and LH beta in hypophysis, and the individual with high expression amount of the marker gene miR-429 is higher than the individual with low expression amount of the marker gene miR-429. The specific regulation mechanism is that miR-429 indirectly promotes the expression of LH beta gene by inhibiting the expression of ZEB1 gene in pituitary, thereby improving the litter size of sows. According to the invention, the farrowing capacity of the sow, particularly the farrowing capacity of about Kjeldahl and southern Anhui black pigs, can be rapidly obtained according to the microRNA marker expression condition related to the litter size of the pig, so that the error of external environmental factors in judging the farrowing capacity is avoided, the complexity in the breeding process is reduced, and the breeding time is greatly shortened through the detection on the molecular level.
Description
Technical Field
The invention belongs to the technical field of livestock molecular biology, and relates to application of a marker gene miR-429 in downstream gene regulation in the aspect of sow farrowing capacity judgment.
Background
Since the 50 s of the twentieth century, the breeding work of domestic and foreign pigs has undergone the transition from fat type to lean meat type with remarkable results, but the progress of genetic improvement is very slow for the reproductive traits with low heritability and the meat quality traits which are difficult to be measured in vivo. Farrowing performance is one of the important factors that determine pig reproductive capacity and economy of the modern pig industry. According to the measurement and calculation of Clutter and the like according to the current breeding scale of the British pigs, as long as the litter size of the pigs is increased by 1-1.5, the British pig industry in British can obtain additional profits of 7 hundred million British pounds each year; therefore, the number of weaned piglets per sow can be increased with less additional investment, and the economic return of the pig-raising producers is increased. Therefore, the litter size trait of the pig is paid more attention by breeders and producers, and has become the key point of the current pig genetic breeding research in China.
The reproductive process of pigs mainly depends on the regulation of hypothalamic-pituitary-gonadal axis, which is influenced by the interaction between genes and the environment. MicroRNA is a small non-coding RNA with the length of about 21-24 nt, and is widely involved in life activities of reproduction, development, virus defense, cell proliferation and apoptosis, fat metabolism and the like of eukaryote through post-transcriptional regulation of target genes. In recent years, studies on pig miRNAs have been increasing, but mainly focused on growth and development, disease occurrence and other related aspects of pigs. The studies on the regulation of porcine reproductive performance by miRNAs are relatively rare and it is not clear how miRNAs function in the hypothalamic-pituitary-gonadal axis.
Disclosure of Invention
The invention aims to use approximately Kyoxia and Anhui black pigs as test objects, understand the expression difference and the expression rule of miR-429 in reproductive axis tissues (pituitary, hypothalamus, ovary, uterus and oviduct) of sows with high and low litter sizes through a real-time fluorescence quantitative PCR technology, analyze the action mechanism of the miRNAs possibly playing a role in which tissues, and provide reference for the breeding and utilization of candidate miRNAs and excellent varieties of pigs.
1. The invention provides application of a marker gene miR-429 in regulating downstream genes in the aspect of judging farrowing capacity of sows, wherein the downstream genes are ZEB1 and LH beta; the downstream gene is regulated and controlled by miR-429 to inhibit the expression of a target gene ZEB1, a negative regulation relation is formed between ZEB1 and LH beta gene, and the expression of the LH beta gene is indirectly up-regulated by miR-429 through inhibiting the expression of the target gene ZEB 1; the marker gene miR-429 is positively correlated with the farrowing capacity of the sow, the target gene ZEB1 is negatively correlated with the farrowing capacity of the sow, and the target gene LH beta is positively correlated with the farrowing capacity of the sow; the farrowing capacity of the sow is judged by analyzing the expression level of the marker gene miR-429.
2. The application provided by the 1, wherein the farrowing capacity of the sow is judged by analyzing the expression levels of a marker gene miR-429 and a target gene ZEB 1.
3. The application provided by the 1 judges the farrowing capacity of the sow by analyzing the expression levels of the marker gene miR-429 and the target gene LH beta.
4. The application provided by the 1 judges the farrowing capacity of the sow by analyzing the expression levels of the marker gene miR-429, the target gene LH beta and the target gene ZEB 1.
5. The application provided by any one of the above 1-4, the application method specifically comprises the following steps: (1) tissue RNA extraction: extracting oviduct and pituitary RNA of different individual sows; (2) designing a primer: respectively designing a q-RT-PCR primer ssc-miR-429 of a candidate gene miR-429, a q-RT-PCR primer ZEB1 of ZEB1 and a q-RT-PCR primer LH beta of LH beta according to a target gene to be analyzed; (3) reverse transcription to synthesize cDNA: synthesizing cDNA (complementary deoxyribonucleic acid) from the total RNA obtained in the reverse transcription step (1) by using a reverse transcription kit; (4) determining the relative expression amounts of the candidate genes miR-429, ZEB1 and LH beta in the oviduct and pituitary of the sow by adopting a q-RT-PCR method; (5) according to the expression level of miR-429 in the oviduct and the pituitary, the expression level of ZEB1 and LH beta in the pituitary; judging the relative high and low farrowing capacity among different sow individuals;
wherein the sequence of the primer ssc-miR-429 is shown in SEQ ID NO. 1;
the upstream sequence of the primer pair LH beta is shown as SEQ ID NO.2, and the downstream sequence is shown as SEQ ID NO. 3;
the upstream sequence of the primer pair ZEB1 is shown as SEQ ID NO.4, and the downstream sequence is shown as SEQ ID NO. 5.
6. The application provided by the 5, wherein the step (2) further comprises the design of an internal reference gene primer, wherein the internal reference gene of miR-429 is U6, and the primer sequence is shown in SEQ ID NO. 6; the internal reference genes of LH beta and ZEB1 are beta-Actin, the sequence of the upstream primer is shown as SEQ ID NO.7, and the sequence of the downstream primer is shown as SEQ ID NO. 8.
7. The use as provided in 5 above, wherein, in the step (3), the reverse transcription kit Invitrogen code: a11193051 carries out transcription turning, a reverse transcription system is 20 mu L, in a miR-429 reverse transcription process system, 1 mu L of total RNA, 2 mu L of SuperScriptR enzyme mixture, 4 mu L of reaction mixture and 20 mu L of ultrapure water are added; the reaction conditions are as follows: inactivating reverse transcriptase at 37 deg.C for 60min, and maintaining at 95 deg.C for 5 sec;
in a reverse transcription process system of LH beta and ZEB1, 2.0 mu L of total RNA, 1 mu L of gDNA Eraser, 2.0 mu L of 5 XgDNA Eraser Buffer and 20 mu L of ultrapure water are added; the reaction conditions are as follows: reacting at 37 ℃ for 15min, and maintaining at 85 ℃ for 5sec to inactivate reverse transcriptase;
the q-RT-PCR method in the step (4) comprises the following reaction system: miR-429 as a 20-L reaction system, EXPRESSGreenERTMqPCR green fluorescent dye 10 μ L, primer ssc-miR-429 2 μ L, cDNA 2 μ L adding ultrapure water to 20 μ L; LH beta reaction System, iTaqTMUniversalGreen Supermix Green fluorescent dye 7.5 μ L, primer pair LH β upstream and downstream sequences 0.5 μ L each, cdna1.5 μ L, ultrapure water added to 20 uL: the ZEB1 reaction system is the same as LH beta, and the primer pair is ZEB 1;
the reaction process is as follows: miR-429 is performed for 40 cycles of 95 ℃ for 20s, 95 ℃ for 5s and 60 ℃ for 20s, and fluorescence values are collected at 60 ℃ for 20 s; LH beta and ZEB1 are at 95 ℃ for 3min, 95 ℃ for 5s, 60 ℃ for 30s for 40 cycles, and fluorescence values are collected at 60 ℃ for 30 s; wherein the sow breeds are Anhui south black pigs and Yorkshire pigs.
8. The invention also provides a research method of a marker gene miR-429 on a downstream gene regulation mechanism, the method takes southern Anhui black pigs and Yorkshire pigs as objects, and a dual-luciferase experiment determines that ssc-miR-429 in the pigs is targeted to a 3' -UTR region of ZEB 1; the targeting relationship of transcription factors ZEB1 and LH beta in pigs is confirmed by a gel migration test.
9. The method of claim 8, wherein the vector used in the dual luciferase gene comprises a luciferase reporter vector: pGL3-Control, restriction enzyme site Xba I; miRNA expression vector: pmr-mcherry, the used restriction enzyme cutting sites are Bgl II and Xba I; the primers comprise PGL3-ZEB1 and ssc-miR-429, wherein the upstream sequence of the primer PGL3-ZEB1 is shown as SEQ ID NO.9, and the downstream sequence is shown as SEQ ID NO. 10; the upstream sequence of the primer ssc-miR-429 is shown in SEQ ID NO.11, and the downstream sequence is shown in SEQ ID NO. 12.
10. The research method of the above 8, wherein the DNA probes in the gel migration test are T1 and T2, wherein the upstream sequence of T1 is shown as SEQ ID NO.13 and the downstream sequence is shown as SEQ ID NO. 14; the upstream sequence of T2 is shown in SEQ ID NO.15, and the downstream sequence is shown in SEQ ID NO. 16.
The concept of comparison provided by the application is comparison among individuals, and the farrowing capacity among different individuals can be determined according to the expression amounts of the marker gene miR-429, the target gene ZEB1 and LH beta among different individuals. "high" and "low" are obtained by comparing data between individuals and are a relative concept.
The invention has the following advantages:
1. the application obtains the targeting relationship among miR-429, ZEB1 and LH beta in the pig pituitary, fills the gap of the prior art, obtains the relationship between the farrowing capacity of the sow and the expression difference of the candidate genes, and provides reference for breed breeding and new strain establishment in the future.
2. According to the invention, the difference of miR-429 expression amounts in the pituitary and the oviduct in the sows, particularly southern Anhui black pigs and Yorkshire pigs, can be used for rapidly judging the litter size between different sow individuals, and the difference of ZEB1 and LH beta expression amounts in the pituitary can be combined to more accurately and rapidly compare the litter size between different sow individuals, so that the error of the judgment of the litter size by external environmental factors can be avoided, the complexity in the breeding process can be reduced, and the breeding time can be greatly shortened by the detection on the molecular level.
Drawings
FIG. 1 Total RNA assay results.
FIG. 2 expression pattern of miR-429 in ovary, uterus, oviduct, hypothalamus, pituitary of approximately Kyoxia and Anhui black pigs. Wherein ". star" shows a significant difference (P < 0.01), ". star" shows a significant difference (P < 0.05).
FIG. 3 differential analysis of miR-429 expression in ovary, uterus, oviduct, hypothalamus and pituitary of about Kyoxia high and low farrowing sows. Wherein ". star" shows a significant difference (P < 0.01), ". star" shows a significant difference (P < 0.05).
FIG. 4 is an analysis of expression difference of miR-429 in ovaries, uteri, oviducts, hypothalamus and pituitary of high-and-low-yield sows in southern Anhui. Wherein ". star" shows a significant difference (P < 0.01), ". star" shows a significant difference (P < 0.05).
FIG. 5 pGL3-Control vector map.
FIG. 6 pmr-mcherry vector map.
FIG. 7 expression difference of ZEB1 in tissues of ovary, uterus, oviduct, hypothalamus, pituitary and the like of approximately Kyoto high litter group and low litter group. Wherein ". star" shows a significant difference (P < 0.01), ". star" shows a significant difference (P < 0.05).
FIG. 8 shows the difference in LH β expression in the tissues of ovary, uterus, oviduct, hypothalamus, pituitary and the like in approximately Kyowa litter group and litter group. Wherein ". star" shows a significant difference (P < 0.01), ". star" shows a significant difference (P < 0.05).
FIG. 9 expression and differential analysis of ZEB1 in ovary, uterus, oviduct, hypothalamus, pituitary and other tissues of southern Anhui black pig. Wherein ". star" shows a significant difference (P < 0.01), ". star" shows a significant difference (P < 0.05).
FIG. 10 expression and differential analysis of LH β in the ovary, uterus, oviduct, hypothalamus, pituitary and other tissues of southern Anhui black pig. Wherein, the difference is extremely significant (P < 0.01) ", the difference is significant (P < 0.05)")
FIG. 11 ssc-miR-429 and ZEB1 determined sequences were compared with the designed sequences. Wherein, the graph A shows the sequence comparison of ssc-miR-429 and the sequence cloned to the miRNA expression vector pmr-mcherry; panel B shows a sequence comparison of ZEB1 and the cloned miRNA expression vector bifluorescent detection vector pGL 3-Control.
FIG. 12 transfection effects of different concentrations of Lipofectamine TM 2000. Wherein, Panel A shows the transfection effect at a concentration of 1 ul; panel B shows the effect of transfection at a concentration of 2 ul; panel C shows the effect of transfection at a concentration of 5 ul.
FIG. 13 fluorescence ratio of empty vector and vector with ssc-miR-429. Wherein ". star" is very significant in the difference (P < 0.01).
FIG. 14 is a standard curve prepared from absorbance data of standard substance with different concentrations measured by microplate reader A562
FIG. 15 EMSA results of interaction of DNA probes T1, T2 with white pig uterine nucleoprotein. Wherein 1 is a null probe, 2 is a competition, 3 is T1, 4 is a null probe, 5 is a competition T2, and 6 is T2.
Detailed Description
The present invention will be specifically described with reference to the following examples.
Example 1:
1.1 test subjects
The used joker summer and southern Anhui black pigs for this experiment were taken from the pig farm of the university of agriculture in Anhui. Carrying out normal distribution analysis by counting the number born of the sow, selecting 3 healthy sows which have the number born distributed at two tails and consistent body condition and age in the intermission period, slaughtering and taking tissues such as ovary, pituitary, hypothalamus, oviduct, uterus and the like, and storing by liquid nitrogen for extracting total RNA. Sample information is shown in table 1.
TABLE 1 sample information
Note: the average litter size in the tables is the mean. + -. standard error
1.2 Main instruments and test reagents
1.2.1 Main Instrument
See table 2.
TABLE 2 Main instruments
1.2.2 Primary reagents
See Table 3
TABLE 3 major reagents
Wherein the reagents such as absolute ethyl alcohol, isopropanol, chloroform, DEPC treated water, agarose, 10 xTBE and the like are imported or domestic split charging reagents and are analytically pure.
1.3 Experimental methods
1.3.1 miR-429 primer design and Synthesis
Designing an upstream specific primer by a tailing method according to a mature sequence of miR-429 of a pig in a latest miRase database, wherein a downstream general primer is provided by an Invitrogen kit; through the experimental result of a fluorescent quantitative standard curve, U6 is selected as an internal reference gene of miRNAs to carry out RT-PCR, and experimental primers are synthesized by Shanghai Production gene company.
TABLE 4 primer sequences for genes and miRNAs
Note: f is an upstream primer, R is a downstream primer
1.3.2 Total RNA extraction and reverse transcription
1.3.2.1 Total RNA extraction
The total RNA extraction in this experiment was performed by TRIzol (Invitrogen) extraction. The operation steps are as follows:
after the sample is rapidly ground by liquid nitrogen, a proper amount of tissue is added into 1ml of TRIzol, the mixture is shaken and kept stand at room temperature to be fully cracked, the mixture is centrifuged at 13000rpm for 5min, and then the supernatant in the tube is transferred to a new 2.0ml of EP tube (if the sample is fat-rich tissue, the grease on the upper layer needs to be removed).
Adding chloroform, covering the tube cover tightly, shaking and mixing uniformly on a vortex oscillator, and standing at room temperature to naturally split phases.
Centrifugation at 13000rpm at 4 ℃ will result in a mixture that will separate into three layers: the lower red layer is phenol-chloroform organic phase, the middle layer and colorless upper aqueous phase, and RNA is mainly concentrated in the aqueous phase.
The supernatant was transferred to a new 2.0ml EP tube (care was taken not to suck the middle and lower layers), chloroform was added, the mixture was shaken and mixed on a vortex shaker for 15 seconds, allowed to stand at room temperature to allow natural phase separation, and centrifuged at 13000rpm at 4 ℃.
Transferring the upper layer water phase into a new 1.5ml EP tube, marking the project name, sample name and date on a centrifuge tube, adding isopropanol with the same volume, mixing uniformly, and standing at-80 ℃ or dry ice for a period of time.
Centrifugation was carried out at 13000rpm at 4 ℃ to discard the supernatant.
Adding 1ml of 75% ethanol into the RNA precipitate, reversing and uniformly mixing for 5s, centrifuging at 4 ℃ and 13000rpm for 5min, and removing the supernatant; and 7, repeating the step.
Centrifuge at 13000rpm for 1min at 4 ℃ and carefully discard the excess liquid with a pipette tip.
Drying the RNA precipitate in an ultraclean workbench for about 1-2min (the RNA is not easy to dry, otherwise the RNA is difficult to dissolve), dissolving the RNA precipitate with a proper amount of RNase-Free ddH2O, gently blowing the precipitate with a pipette if necessary, and storing at-80 ℃ after the RNA precipitate is completely dissolved.
1.3.2.2RNA quality testing
1) And (3) detecting the concentration and purity of the RNA: taking 1 mu L of RNA solution to be detected, and determining the concentration and purity of the RNA on an ultramicro ultraviolet spectrophotometer. RNA purity OD260/OD280, purity between 1.8-2.0 as qualified RNA sample, can be reverse transcription. If the purity value is lower than 1.8, protein pollution exists; if the purity value is higher than 2.0, there is contamination with other nucleic acids.
2) Detecting RNA quality by formaldehyde denatured gel: 2g agarose was weighed, 20mL 10 XTBE, 144mL DEPC water was added, the mixture was heated to complete dissolution in a microwave oven, 5. mu.L 10mg/mL EB solution was added after cooling to about 60 ℃, 36mL formaldehyde was added in a fume hood, and after standing for a period of time, gelation was carried out. Taking 4 mu L of RNA sample, adding 1 mu L of 5 XRNA Loading buffer, heating in a 70 ℃ water bath kettle for 10min, placing on ice for quenching, placing the mixed sample on formaldehyde denaturing gel, carrying out electrophoresis detection at 3-5V/cm, and observing an electrophoresis strip.
1.3.2.3 reverse transcription and quantitation of miRNA
A reverse transcription reaction solution was prepared using a reverse transcription kit (Invitrogen code: A11193051) by the following composition, as shown in Table 6.
TABLE 6 miRNA reverse transcription reaction protocols
The reaction conditions for the reverse transcription were as follows: the reaction was maintained at 37 ℃ for 60min and 95 ℃ for 5sec (reverse transcriptase inactivation reaction). After the sample cDNA obtained after reverse transcription was used for PCR detection, RNase Free water was added to 40. mu.L. The reverse transcription product was stored in a freezer at-20 ℃.
The expression quantity of the pig miR-429 and internal reference gene U6 genes is detected by a real-time fluorescent quantitative PCR method, and the reaction is carried out on a Bio-rad CFX96 qPCR fluorescent quantitative PCR system. The reaction system was 20. mu.L, and the specific procedures are shown in Table 7:
TABLE 7 RT-PCR reaction procedure
Each sample was repeated 3 times. After the reaction cycle was completed, the product purity of RT-PCR was checked by the dissolution profile.
1.3.2.4 Gene expression data analysis
Analysis of expression level of Gene: the statistical analysis of the validity data was carried out by the 2- Δ Δ Ct method. The relative expression quantity of the target gene is 2-delta CT, the delta Ct represents an internal reference gene, wherein the miRNA takes U6 as the internal reference gene, the average value of the Ct difference values of the target gene and the internal reference gene of a control group is taken as a reference value, x represents any sample, and the formula is as follows:
ΔΔCt=(Ct.Target gene-Ct.Reference gene)x-(Ct.Target gene-Ct.Reference gene)control
the expression quantity of the target gene of each sample is calculated by the formula, after the internal reference gene is corrected, the data is expressed by mean value plus or minus standard error (M plus or minus SE), the results of experimental data are statistically analyzed and plotted by GraphPad Prism 6 software, and the significance of the mean value difference is analyzed and compared by a t-test method. P < 0.01 indicates a significant level of difference, and P < 0.05 indicates a significant level of difference.
1.4 results and analysis
1.4.1 extraction and detection of Total RNA
As can be seen from the figure, the extracted total RNA is detected by 1% agarose gel electrophoresis, and three clear bands are seen, namely 28S, 18S and 5S rRNA from top to bottom. The ratio of OD260/OD280 is 1.9-2.1, which indicates that the extracted total RNA has good quality and no pollution of protein and other impurities, and can be used for carrying out subsequent reverse transcription tests.
1.4.2 expression differences of miR-429 in reproductive axis tissues of two different varieties of sows
Quantitative experiments show that the high expression tissues of the miR-429 are different. miR-429 is highly expressed only in the fallopian tubes and pituitary. In the same tissue, miR-429 expression in approximately Kwangsu pituitary is significantly lower than that of southern Anhui black pig (P < 0.01), and expression in approximately Kwangsu oviduct is significantly higher than that of southern Anhui black pig (P < 0.01).
1.4.3 expression rule of miR-429 in reproductive axis tissues of sows with different litter sizes of the same variety
In approximately g, the expression of miR-429 in both the fallopian tube and pituitary in the high-yielding group was higher than that in the low-yielding group (P < 0.01 or P < 0.05). In southern Anhui black pigs, the expression of miR-429 in both pituitary and oviduct of the high-yielding group was higher than that of the low-yielding group (P < 0.01).
1.5 discussion
1.5.1 Effect of miR-429 on litter size in sows
miR-429 belongs to miR-200 family, and the research thereof mostly focuses on the research of human cancers. Research in pigs, particularly in the breeding of pigs, is very scarce. According to quantitative data of miR-429 in tissues of a reproductive axis in the experiment, miR-429 is almost only expressed in two tissues of an oviduct and a pituitary, and the expression of a high-yield group is higher than that of a low-yield group in the two tissues. Suggesting that miR-429 probably exerts a regulatory effect on litter traits in the pituitary and hypothalamus.
The oviduct has extremely complex and fine physiological functions and plays an important role in egg picking, sperm capacitation, ovum fertilization, fertilized egg delivery and survival and development of early embryos, so the condition of the oviduct has important significance in the smooth progress of reproductive behaviors. We can conclude that miR-429 might have an up-regulating effect on the litter size of sows in the pituitary and oviducts of sows.
1.6 summary knot
The experiment discusses the expression rule of miR-429 in the reproductive axis tissue of the sow and the expression difference of the miR-429 in high-farrowing sow groups and low-farrowing sow groups. By analyzing quantitative data of miR-429 in reproductive axis tissues of sows with different litter sizes of two breeds, the miR-429 can possibly generate an up-regulation effect on the farrowing traits of the sows in oviducts and hypophysis of the sows.
Example 2
2.1 test materials
The experimental samples used in the real-time fluorescence quantification experiment were the same as in example 1.
In addition, 1 healthy koxia sow is selected from a pig farm in the experiment base of Anhui agricultural university, tissues such as uterus and heart are slaughtered and stored in liquid nitrogen. Instructions for use:
since the quantitative test of example 1 showed that ZEB1 has a high level of expression in the uterus, the uterus cells of the Yorkshire sow were selected for extracting nucleoprotein for EMSA test.
DNA is extracted from heart tissue of about Kyara sow and used for preparing carrier required by dual-luciferase experiment
2.2 preparation of common instruments and reagents
Common instruments are shown in Table 8.
TABLE 8 common instruments
The usual reagents are shown in Table 9.
TABLE 9 common reagents
The following reagents were also prepared:
(1) 1.0% agarose electrophoresis gel: 0.5g agarose is weighed and added into 50mL IXTBE electrophoresis buffer solution, the mixture is fully heated and dissolved in a microwave oven, 2-3ul Gelstain is added after the mixture is cooled to 60 ℃, and the mixture is fully mixed.
(2) Preparation of 6% non-denatured polyacrylamide gel: in a 15ml test tube, ddH2O7.15ml, 30% polyacrylamide solution 2ml, 5 XTBE 1ml, glycerol 175ul, 10% APS 75ul, TEMED 8ul were placed in this order and mixed well.
1.3 Experimental methods
1.3.1 real-time fluorescent quantitation primer design and Synthesis of ZEB1 and LH β
Designing upstream and downstream primers of a target gene by using Primer Premier 5.0 software according to mRNA sequences (sequence numbers are XM-003482813.2 and NM-214080.1) of ZEB1 and LH beta of pigs in a GenBank database; and through the experimental result of a fluorescent quantitative standard curve, selecting beta-Actin (with the sequence number of XM-003124280.2) as the internal reference genes of the mRNAs to carry out RT-PCR, and synthesizing the primers of each gene by Shanghai. The primers for the upstream and downstream of each target gene are shown in Table 10.
TABLE 10 primers used in the assay
Note: f is an upstream primer, R is a downstream primer
2.3.2 Dual-luciferase vector and target fragment primer design
The carrier used in the dual-luciferase experiment is responsible for construction by the hybrid fertilizer Walang Biotech company:
(1) luciferase reporter vector: pGL3-Control, restriction site Xba I used. pGL3-Control vector is shown in FIG. 5:
(2) miRNA expression vector: the cleavage site used was Bgl II & Xba I. The pmr-mcherry vector is as in FIG. 6:
combining the prediction results of the miRNA and the target gene ZEB 13' UTR and the information of the used vector and enzyme cutting site to design primers, wherein the primers are synthesized by Shanghai worker, and the specific information of the primers is shown in Table 11:
TABLE 11 primers for Dual luciferase assay
Note: f is an upstream primer, R is a downstream primer
2.3.3 DNA Probe design for EMSA
Combining the combination condition of the transcription factor ZEB1 and the LH beta promoter region of the target gene, selecting two predicted regions to prepare probes T1 and T2, wherein the DNA probe used in the experiment is synthesized by Nanjing Dingding biology, and the sequence information of the probe is shown in Table 12.
TABLE 12 Probe primers for EMSA
Note: f is a forward primer, R is a reverse primer
2.3.4 reverse transcription and quantitation of ZEB1 and LH β
Total mRNA used in this reverse transcription experiment was extracted from run one and the reverse transcription reaction was performed according to the PrimeScriptTM RT reagent kit by TaKaRa with gDNA Eraser (Peffect Real Time) reagent instructions:
the first step is to remove the DNA from the total RNA. mu.L (250 ng/. mu.L) total RNA, 2. mu.L 5 XgDNA Eraser Buffer, 1. mu.L gDNA Eraser were added to a 0.2ml RNase-Free PCR tube, 5. mu.L RNase Free dH2O was added to the tube to a volume of 10. mu.L, centrifuged and placed in a PCR apparatus, pre-denatured at 42 ℃ for 2min, and stored at 4 ℃. The reaction system for removing genomic DNA is shown in Table 13.
TABLE 13 removal of genomic DNA reaction
And secondly, carrying out reverse transcription reaction on the treated product. To the first step reaction was added 4. mu.L of 5 XPrimeScript Buffer 2(for Real Time), 1. mu.L of PrimeScript RT Enzyme Mix I, 1. mu.L of RT Primer Mix, 4. mu.L of RNase Free dH2O in total volume of 20. mu.L, mixed and centrifuged briefly, and the reaction tube was reacted in a PCR apparatus at 37 ℃ for 15min and at 85 ℃/5sec to inactivate the reverse transcriptase. The reverse transcription product (RT product) was stored at-20 ℃ for real-time quantitative PCR after packaging. mRNA reverse transcription system is shown in Table 14.
TABLE 14 mRNA reverse transcription System
The expression levels of ZEB1, LH beta and the internal reference gene beta-Actin of the pig are detected by a real-time fluorescent quantitative PCR method, and the reaction is carried out on a Bio-rad CFX96 qPCR fluorescent quantitative PCR system. The reaction was 20. mu.L, and each sample was repeated 3 times. After the completion of the reaction cycle, the gene quantitative data was processed in the same manner as in example 1.
The specific steps are shown in Table 15.
Table 15 RT-PCR reaction protocol for mRNA
2.3.5 Dual luciferase reporter Gene experiments
2.3.5.1 extraction and sequencing identification of recombinant plasmid
The experiment was performed according to the instructions of the Kit for easy pure Plasmid MiniPrep Kit of Beijing holotype gold organisms:
the overnight culture was removed, centrifuged at 10,000Xg for 1min, and the supernatant removed (as far as possible). If the bacterial liquid brightness is too large, the bacterial liquid can be collected centrifugally for many times.
Adding colorless solution RB (containing RNase A), and shaking to suspend the thallus, wherein small bacterium blocks are not remained.
Adding blue solution LB, turning and mixing 4-6 times to crack thallus completely to form blue bright solution, changing color from semi-bright to bright blue, indicating complete cracking (not more than 5 min).
Add yellow NB solution, mix gently 5-6 times (color change from blue to yellow indicating uniform mixing and complete neutralization) until a compact yellow clump is formed, and stand 2 minutes at room temperature.
Centrifuge at 12,000Xg for 5 minutes, carefully aspirate the supernatant and add to the spin column. Centrifuge at 12,000Xg for 1 minute and discard the effluent. (if the volume of the supernatant is more than 800ul, it can be added to the column in several portions and centrifuged as above to discard the effluent).
250ul of TB solution was added, and the mixture was allowed to stand at room temperature for 10 minutes, centrifuged at 12,000Xg for 1 minute, and the effluent was discarded.
650ul of WB solution was added, and the mixture was centrifuged at 12,000Xg for 1min, and the effluent was discarded.
Centrifugation at 12,000Xg for 1-2 minutes thoroughly removed residual WB.
The column was placed in a clean centrifuge tube and 30-50ul EB or deionized water (pH > 7.0) was added to the center of the column and allowed to stand at room temperature for 1 minute. (EB or deionized water is preheated in water bath at the temperature of 60-70 ℃, and the using effect is better).
10,000Xg centrifugation for 1min, elution of DNA at-20 ℃ storage for sequencing.
2.3.5.2 optimization of Co-transfection conditions
The efficiency of cell cotransfection is influenced by the quantity of liposome, the ratio of liposome to carrier, experimental cells and other factors. This experiment was most suitable for transfection experiments at a cell density of 70% based on previous experimental experience using six well plates with a recommended addition of 2ug of plasmid per well (1ug pmr-mcherry or pmr-mcherry-ssc-mir-429+1ug pGL3-Control-ZEB 1). To find the optimal amount of liposomes added per well, we set 3 different doses of Lipofectamine TM2000 at 1ul, 2ul, 5ul according to the literature and then observe the transfection efficiency.
Before transfection, the cell culture solution was changed to DMEM medium without double antibody, and 293T cells were transfected with plasmids at a cell density of 70%. 125ul of OPTI-MEM was added to 3 EP tubes, 1ul, 2ul and 5ul of Lipofectamine TM2000 were added, mixed by shaking and left to stand for 5 min. 2ug of plasmid (pmr-mcherry-ssc-mir-429+1ug of pGL3-Control-ZEB1) was added to each tube, mixed by shaking, and allowed to stand for 20 min. The mixture after standing is added into a six-well plate, fresh culture solution is replaced after 6 hours, fluorescence is observed for 24 hours, and transfection efficiency is confirmed. Wherein the pmr-mcherry-ssc-mir-429 plasmid carries a mcherry fluorescent dye, and the red light can be used for directly observing the transfection effect under an inverted microscope.
2.3.5.3 cotransfection and dual-luciferase reporter gene activity detection
After determining the optimal addition of Lipofectamine (TM) 2000, two sets of co-transfections were performed in 6-well plates: 1ug pGL3-Control-ZEB1+1ug pmr-mcherry-ssc-mir-429or pmr-mcherry. To ensure the accuracy and reliability of the experiment, we performed 5 biological replicates per group. And (3) replacing fresh culture solution after 6 hours of transfection, and detecting the fluorescence values of luciferase and renilla by using a dual-luciferase reporter gene detection system after 24 hours. Where Renilla fluorescence values were used as an internal control, normalization was performed to eliminate differences in cell number and transfection efficiency.
The method for detecting the fluorescence activity of the Dual luciferase reporter assay system comprises the following steps:
cell lysis: after sucking up the cell culture solution, directly adding 100ml of fully and uniformly mixed reporter gene cell lysate into each hole of 293T cells cultured in a 6-hole plate, and fully lysing the cells;
dissolving the firefly luciferase detection reagent and the renilla luciferase detection buffer solution, and reaching the room temperature. Renilla luciferase assay substrate (100X) was placed in an ice bath or ice box for use.
According to the amount of 100ul required by each sample, a proper amount of renilla luciferase detection buffer solution is taken, and renilla luciferase detection substrate (100X) is added according to the ratio of 1: 100 to prepare the renilla luciferase detection working solution.
The fluorescence detector was turned on according to the instructions, and the measurement time interval was set to 2s and the measurement time was set to 10s.
For each sample, 100ul of firefly luciferase assay reagent was added, and rlu (relative light unit) was measured after mixing well by gun blow. Reporter cell lysates were used as blank controls.
After the above steps are completed, 100ul of renilla luciferase detection working solution is added, and RLU is measured after the solution is evenly beaten by a pipette
In the case of renilla luciferase as an internal control, RLU values measured with firefly luciferase were divided by RLU values measured with renilla luciferase. The degree of activation of the reporter gene of interest is compared based on the obtained ratio.
2.3.6 EMSA experiment
2.3.6.1 extraction of nucleoprotein
The experiment was carried out according to the instructions of the NE-PER Nuclear and cytological Extraction Reagents kit from Thermo Scientific:
(1) flushing a large white pig uterine tissue sample by using precooled PBS; transferring to a1.5 ml centrifuge tube, centrifuging for 3min at 500 Xg; carefully discarding the supernatant for later use;
(2) adding 100ul of precooled CER I (containing Protease Inhibitor); violent votex 15s, ice bath for 10 min;
(3) adding precooled CER II 5.5 ul; violent votex 5s, ice bath for 1 min;
(4) vigorous votex 5s, 16000 Xg, centrifuge for 10 min;
(5) immediately sucking the supernatant into a precooled centrifugal tube to obtain the tissue plasma protein obtained by extraction;
(6) adding 40ul of precooled NER (containing Protease Inhibitor);
(7) violent votex 15s, placed on ice, violent votex 15s every 10min for 40 min;
(8)16000 Xg, centrifuging for 10 min; immediately sucking the supernatant into a precooled centrifugal tube to obtain the tissue nucleoprotein obtained by extraction.
2.3.6.2 protein concentration detection using BCA:
the experiment was performed according to the BCA protein quantification kit instructions of Peking Edley:
according to the quantity of samples, preparing a proper amount of BCA working Solution according to 50 times of volume Solution A and 1 time of volume Solution B (50: 1), and fully and uniformly mixing.
And after the protein B standard substance is completely dissolved, adding the diluted standard substance into a 96-well plate according to the ratio of 0, 1, 2, 4, 8, 12, 16 and 20ul respectively, and adding the diluent to make up to 20 ul.
And C, adding 200ul of BCA working solution into each hole, slightly blowing, uniformly mixing, and standing at 37 ℃ for 45 min.
After cooling to room temperature, absorbance of A562 was measured by a microplate reader. And a standard curve is made according to the measured data to calculate the protein concentration in the sample.
2.3.6.3 EMSA experiments on ZEB1 and LHB
(1) Preparation of 6% non-denatured polyacrylamide gel: in a 15ml test tube, ddH2O 7.15.15 ml, 30% polyacrylamide solution 2ml, 5 XTBE 1ml, glycerol 175ul, 10% APS 75ul, TEMED 8ul are put in sequence;
(2) pre-electrophoresis at 4 deg.c and 100V voltage for 60 min;
(3) preparing a combined reaction solution according to the requirements of an EMSA kit (cargo number: 20148) of PIERCE company, and standing at room temperature for 10 min;
(4) adding biotin-labeled probe, and standing at room temperature for 45 min;
(5) adding 5ul of Loading Buffer into each binding reaction, mixing uniformly, and Loading;
(6) electrophoresis at 4 ℃ and 100V until the length of the gel is 2/3 after bromfenglan electrophoresis;
(7) film transfer: soaking nylon membrane with proper size in 0.5 × TBE for 15min, sequentially placing sponge, filter paper, gel, nylon membrane, filter paper and sponge according to sandwich method, fixing sieve plate, carefully removing all bubbles in sandwich, inserting gel into electrophoresis tank facing cathode, pouring 0.5 × TBE, and transferring under constant current of 300mA for 30 min; ultraviolet crosslinking;
(8) detection of biotin-labeled DNA by chemiluminescence: reference PIERCEThe Chemilmescent EMSA Kit states the operation;
(9) gently preheating a blocking Buffer (blocking Buffer) and a 4 Xrinsing Buffer (Wash Buffer) in a water bath at 50 ℃ until the particles are completely dissolved;
(10) placing the membrane in a clean plastic plate, adding 20ml of sealing buffer solution, and placing on a shaking table to gently shake for 15 min;
(11) sucking 66.7ul of horseradish streptavidin peroxidase substrate into 20ml of sealing buffer solution, and uniformly mixing for later use;
(12) pouring the blocking buffer solution, adding the solution prepared in the step 10, and placing on a shaking table to gently shake for 15 min;
(13) taking 40ml of 4 rinsing buffer solution to 120ml of ddH2O to obtain 1 rinsing buffer solution; transferring the membrane to a new plastic plate, adding 20ml1 rinsing buffer solution, rinsing for 5min, rinsing for 4 times;
(14) transferring the membrane to another new plastic plate, adding 30ml substrate balance buffer solution, and balancing for 5 min;
(15) preparing a Substrate Working Solution (Substrate Working Solution): adding 6ml Luminol/Enhancer Solution into 6ml Stable Peroxide Solution, mixing, and keeping away from light for use;
(16) taking out the membrane from the substrate balance buffer solution, placing the membrane into a new clean plate with the right side facing upwards, pouring the substrate working solution into the surface of the membrane, and placing the membrane for 5min in a dark place;
(17) taking the membrane out of the substrate working solution, and sealing the membrane by using a plastic packaging membrane to avoid bubbles and wrinkles;
(18) the film was exposed to X-ray film in a dark room, developed, fixed, developed, and the results were recorded by exposure.
2.4 results
2.4.1 expression rule of ZEB1 and LH beta genes in reproductive axis tissues of sows of the same breed with different litter sizes
As shown in FIGS. 7-8, the expression of pituitary ZEB1 in the high yield group was significantly lower than that in the low yield group (P < 0.01) in about g. The expression of pituitary LH beta in the high-yield group is remarkably higher than that in the low-yield group (P is less than 0.01).
As shown in FIGS. 9-10, in southern Anhui black pigs, the expression of ZEB1 was lower in the pituitary gland of the high-yielding group than in the low-yielding group (P < 0.01). LH beta is expressed mainly in pituitary gland with tissue specificity, and the high-yielding group is higher than the low-yielding group (P < 0.01).
2.4.2 Dual luciferase assay
2.4.2.1 sequencing results and analysis of recombinant plasmids
According to the sequence comparison of the fragment sequence obtained by designing a primer and a sequencing result, ssc-miR-429 and ZEB 13' UTR are successfully cloned into a miRNA expression vector pmr-mcherry and a double-fluorescein detection vector pGL3-Control respectively, the determined sequences are completely consistent with the design as shown in figure 11, and the sequence can be used in a subsequent double-fluorescence detection experiment.
2.4.2.2 optimization of transfection conditions
In the experiment, 3 experimental groups A, B and C with different addition amounts are established according to the optimal addition amount of Lipofectamine TM 2000. Since the transfected pmr-mcherry-ssc-mir-429 is a protein with mcherry fluorescence, the fluorescence luminescence read-out level can be observed under an inverted microscope to evaluate the transfection efficiency. The concrete results are shown in FIG. 12
The results showed that the transfection efficiency was highest at 5ul/well of Lipofectamine TM 2000. Thus in the following co-transfection experiment, transfection was performed using Lipofectamine (TM) 2000 at 5 ul/well.
2.4.2.3 detection of dual-luciferase reporter gene activity
The experiment was performed according to the protocol of the Promega Dual Luciferase reporter assay 1910 Dual fluorescent reporter System with Fluoroskan assay FL fluorescent chemiluminescent microplate reader to obtain fluorescence values, all Luciferase fluorescence values in the raw data were then normalized with Renilla and plotted with GraphPad Prism 6 FIG. 13
As can be seen from FIG. 13, the fluorescence ratio between the empty vector experimental group and the carrier with ssc-miR-429 experimental group shows that the fluorescence value of the empty vector experimental group is very significantly higher than that of the carrier with ssc-miR-429 experimental group (P < 0.01). Indicating that ssc-miR-429 targets the 3' -UTR region of ZEB 1.
24.3 EMSA experiment
2.4.3 concentration of BCA assay protein
According to the measurement method provided by the BCA kit: measuring absorbance of standard substance with different concentrations in A562 with microplate reader, and making standard curve according to data
TABLE 16 absorbance of standards of different concentrations determined by BCA method
According to the standard curve and the absorbance of the sample A562, the concentration of the protein extracted from the uterus of the white pig is calculated to be 16.46mg/ml, which meets the requirements of the next EMSA experiment.
2.4.4 EMSA test identification results
The EMSA results showed that bands in which the DNA probe was bound to the target protein and migrated appeared in the gel wells of FIG. 15, T1 and T2, indicating that transcription factor elements capable of specifically binding to the DNA probe did exist in the nuclear protein of the sample. However, the extracted nucleoprotein contained endogenous biotin, so that both competitive T1 and competitive T2 showed bands.
From the quantitative data of miR-429, ZEB1 and LH beta in the test results, miR-429 has the tendency of down-regulating ZEB1 in the pituitary and ZEB1 also has the tendency of down-regulating LH beta, so that miR-429 possibly has a regulation mechanism for up-regulating the fertility candidate gene-LH beta by down-regulating the target gene ZEB1 in the pituitary of pigs.
The miRNA can perform post-transcriptional regulation through a 3' UTR region of a target gene, thereby playing a role in regulating the protein expression level of the target gene. According to the present example, the fluorescence value of the empty vector group was higher than that of the vector group with ssc-miR-429 (P < 0.01), and we can confirm that there is a targeting relationship between miR-429 and ZEB1 in pigs, and that the targeting relationship can be up-regulated. As a result of EMSA binding in the test, we found that a band in which the probe binds to the target protein and migrates appears only in the electrophoresis lanes of the specific DNA probes T1 and T2, indicating that transcription factor elements capable of specifically binding to the DNA probes do exist in the nuclear protein of the sample. This makes more clear the targeting concerns of the transcription factors ZEB1 and LH β. In conclusion, the existing experimental results are utilized by the inventor to preliminarily verify that miR-429 can regulate the LH beta up by down-regulating ZEB1 in the pituitary.
The above example firstly analyzes the expression rule of miR-429 in reproductive tissues of high-low yield about Kyoxia and southern Anhui black pigs, and deduces that miR-429 may influence the farrowing performance of pigs. And then, verifying the molecular mechanism of miR-429 for regulating the piglet farrowing characters through a plurality of verification experiments such as real-time fluorescence quantification, dual-luciferase reporter genes, electrophoretic mobility and the like. To obtain:
(1) miR-429 participates in pig reproduction regulation;
(2) miR-429 can indirectly regulate the expression of LH beta gene by inhibiting the expression of a target gene ZEB1, thereby regulating the farrowing performance of pigs.
It will be understood that the above-described embodiments are merely illustrative of the principles of the invention, which is not limited thereto, and that various modifications and changes can be made by those skilled in the art without departing from the spirit of the invention, which also falls within the scope of the invention.
Claims (1)
1. The application of the marker gene miR-429 in downstream gene regulation in sow farrowing potential judgment is characterized in that: the downstream genes are ZEB1 and LH beta; the downstream gene is regulated and controlled by miR-429 to inhibit the expression of a target gene ZEB1, a negative regulation relation is formed between ZEB1 and LH beta gene, and the expression of the LH beta gene is indirectly up-regulated by miR-429 through inhibiting the expression of the target gene ZEB 1; the marker gene miR-429 is positively correlated with the farrowing potential of the sow, the target gene ZEB1 is negatively correlated with the farrowing potential of the sow, and the target gene LH beta is positively correlated with the farrowing potential of the sow;
judging the farrowing potential of the sow by analyzing the expression levels of a marker gene miR-429, a target gene LH beta and a target gene ZEB 1;
the method specifically comprises the following steps: (1) tissue RNA extraction: extracting oviduct and pituitary RNA of different individual sows; (2) designing a primer: respectively designing a q-RT-PCR primer ssc-miR-429 of a candidate gene miR-429, a q-RT-PCR primer ZEB1 of ZEB1 and a q-RT-PCR primer LH beta of LH beta according to a target gene to be analyzed; (3) reverse transcription to synthesize cDNA: synthesizing cDNA (complementary deoxyribonucleic acid) from the total RNA obtained in the reverse transcription step (1) by using a reverse transcription kit; (4) determining the relative expression amounts of the candidate genes miR-429, ZEB1 and LH beta in the oviduct and pituitary of the sow by adopting a q-RT-PCR method; (5) according to the expression level of miR-429 in the oviduct and the pituitary, the expression level of ZEB1 and LH beta in the pituitary; judging the relative high and low farrowing capacity among different sow individuals;
wherein the sequence of the primer ssc-miR-429 is shown as SEQ ID number 1;
the upstream sequence of the primer pair LH beta is shown as SEQ ID number 2, and the downstream sequence is shown as SEQ ID number 3;
the upstream sequence of the primer pair ZEB1 is shown as SEQ ID number 4, and the downstream sequence is shown as SEQ ID number 5;
the step (2) also comprises the design of an internal reference gene primer, wherein the internal reference gene of miR-429 is U6, and the primer sequence is shown as SEQ ID number 6; the internal reference genes of LH beta and ZEB1 are beta-Actin, the sequence of the upstream primer is shown as SEQ ID number 7, and the sequence of the downstream primer is shown as SEQ ID number 8;
performing reverse transcription by using a reverse transcription kit in the step (3), wherein a reverse transcription system is 20 muL, in a miR-429 reverse transcription process system, 1 muL of total RNA, 2 muL of reverse transcriptase mixture, 5X Reaction Mix4 muL of total RNA, and ultrapure water is added to 20 muL; the reaction conditions are as follows: inactivating reverse transcriptase at 37 deg.C for 60min, and maintaining at 95 deg.C for 5 sec;
in a LH beta and ZEB1 reverse transcription process system, 2.0 muL of total RNA, 1 muL of gDNA Eraser, 2.0 muL of 5 XgDNA Eraser Buffer and 20 muL of ultrapure water are added; the reaction conditions are as follows: reacting at 37 ℃ for 15min, and maintaining at 85 ℃ for 5sec to inactivate reverse transcriptase;
the q-RT-PCR method in the step (4) comprises the following reaction system: miR-429 is a 20 muL reaction system, EXPRESS SYBR GreenER ™ qPCRSuperMix Universal green fluorescent dye 10 muL, 2 muL primer ssc-miR-429 and cDNA 2 muL are added with ultrapure water to 20 muL; an LH beta reaction system, 7.5 mu L of iTaq Universal SYBR Green Supermix Green fluorescent dye, 0.5 mu L of each upstream and downstream sequences of a primer pair LH beta, 1.5 mu L of cDNA1.5 mu L and ultrapure water added to 20 uL; the ZEB1 reaction system is the same as LH beta, and the primer pair is ZEB 1;
the reaction process is as follows: miR-429 is performed for 40 cycles of 95 ℃ for 20s, 95 ℃ for 5s and 60 ℃ for 20s, and fluorescence values are collected at 60 ℃ for 20 s; LH beta and ZEB1 are at 95 ℃ for 3min, 95 ℃ for 5s, 60 ℃ for 30s for 40 cycles, and fluorescence values are collected at 60 ℃ for 30 s; wherein the sow breeds are Anhui south black pigs and Yorkshire pigs.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610841933.2A CN106434912B (en) | 2016-09-22 | 2016-09-22 | Application of microRNA marker related to litter size of pig |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610841933.2A CN106434912B (en) | 2016-09-22 | 2016-09-22 | Application of microRNA marker related to litter size of pig |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106434912A CN106434912A (en) | 2017-02-22 |
CN106434912B true CN106434912B (en) | 2021-05-18 |
Family
ID=58165900
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610841933.2A Active CN106434912B (en) | 2016-09-22 | 2016-09-22 | Application of microRNA marker related to litter size of pig |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106434912B (en) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5939264A (en) * | 1996-07-19 | 1999-08-17 | Iowa State University Research Foundation, Inc. | Genes and genetic markers for improved reproductive traits in animals |
CN105112549B (en) * | 2015-09-25 | 2018-08-28 | 四川农业大学 | A kind of microRNA molecule label miR-23a of quick detection sow Oocyte quality and its application |
CN105112548B (en) * | 2015-09-25 | 2018-08-24 | 四川农业大学 | A kind of miRNA molecule mark miR-145 of quick detection sow embryo survival and its application |
-
2016
- 2016-09-22 CN CN201610841933.2A patent/CN106434912B/en active Active
Also Published As
Publication number | Publication date |
---|---|
CN106434912A (en) | 2017-02-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Cai et al. | Identification and characterization of human ovary-derived circular RNAs and their potential roles in ovarian aging | |
Kang et al. | A 14-bp functional deletion within the CMTM2 gene is significantly associated with litter size in goat | |
Melo et al. | Multitrait meta-analysis identified genomic regions associated with sexual precocity in tropical beef cattle | |
CN103898231B (en) | A kind of SNP marker relevant to pork pH proterties and application thereof | |
Ji et al. | miR-135a targets and regulates prolactin receptor gene in goat mammary epithelial cells | |
CN113549700B (en) | Molecular marker related to porcine intramuscular fat character and application of molecular marker in pig breeding | |
CN110511903A (en) | A kind of Study on Molecular Mechanism method and its application of miR-21-5p targeting Smad7 regulation pig ovary granular cell | |
CN113817845A (en) | miRNA (micro ribonucleic acid) molecule related to porcine luminal ovarian follicle atresia and application thereof | |
Chen et al. | MicroRNA-27a activity is not suppressed in porcine oocytes | |
Yao et al. | Unconservative_15_2570409 suppresses progesterone receptor expression in the granulosa cells of Hu sheep | |
CN106434912B (en) | Application of microRNA marker related to litter size of pig | |
CN114959057B (en) | CircRNA related to porcine skeletal muscle satellite cell proliferation and application thereof | |
CN110982910A (en) | circRNA related to boar reproduction traits and application | |
CN109402269A (en) | One kind miRNA relevant to duck enteron aisle oxidative stress and its application | |
Feng et al. | Expression analysis of differentially expressed miRNAs in male and female chicken embryos | |
CN111876497B (en) | Method for identifying or assisting in identifying quality of animal semen | |
CN112011624B (en) | Application of miR-155 as marker in identification or auxiliary identification of animal semen quality | |
CN112011628A (en) | LncRNA marker related to Hu sheep muscle cell proliferation as well as detection primer and application thereof | |
CN111172161A (en) | Long non-coding RNA and application thereof in diagnosis/treatment of preeclampsia | |
CN107937523B (en) | Lung cancer diagnosis marker microRNA-3607-3p and application thereof in medicines and diagnosis kit | |
Urbański et al. | A new SNP in the promoter region of the porcine MYF5 gene has no effect on its transcript level in m. longissimus dorsi | |
Huang et al. | Xie | |
CN113717975B (en) | miRNA marker related to pig hairless character and application thereof | |
CN115927338A (en) | Non-coding RNA for regulating and controlling CART expression in hypothalamus of cattle and application thereof | |
CN109628609B (en) | Method for detecting 4 repeated deletion polymorphic sites of Chinese cattle PPP2R2B gene and application |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20211222 Address after: 246600 Huangni village, Laibang Town, Yuexi County, Anqing City, Anhui Province Patentee after: ANHUI HUI MOUNTAIN AGRICULTURAL LIMITED BY SHARE Ltd. Address before: 230036 No. 130 Changjiang West Road, Hefei, Anhui Patentee before: Anhui Agricultural University |
|
TR01 | Transfer of patent right |